Cargando…

RGL2 Drives the Metastatic Progression of Colorectal Cancer via Preventing the Protein Degradation of β-Catenin and KRAS

SIMPLE SUMMARY: Aberrant activation of the Wnt/β-catenin pathway due to APC (adenomatous polyposis coli) loss and Kirsten ras (KRAS) mutation is highly associated with malignant evolution, e.g., metastasis, of colorectal cancer (CRC). Ral guanine nucleotide dissociation stimulator-like (RGL) protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Meng-Shun, Yuan, Lan-Ting, Kuei, Chia-Hao, Lin, Hui-Yu, Chen, Yen-Lin, Chiu, Hui-Wen, Lin, Yuan-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067854/ https://www.ncbi.nlm.nih.gov/pubmed/33917100 http://dx.doi.org/10.3390/cancers13081763

Ejemplares similares

Structural insights into the complex of oncogenic KRas4B(G12V) and Rgl2, a RalA/B activator
por: Tariq, Mishal, et al.
Publicado: (2023)

Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation
por: Liu, Chunqi, et al.
Publicado: (2021)

The COP9 Signalosome regulates seed germination by facilitating protein degradation of RGL2 and ABI5
por: Jin, Dan, et al.
Publicado: (2018)

Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy
por: Chen, Kuen-Feng, et al.
Publicado: (2015)

Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
por: Lin, Chung-Ming, et al.
Publicado: (2017)

Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
por: Lin, Yu-Lin, et al.
Publicado: (2014)

The Gαh/phospholipase C-δ1 interaction promotes autophagosome degradation by activating the Akt/mTORC1 pathway in metastatic triple-negative breast cancer
por: Lin, Hui-Yu, et al.
Publicado: (2020)

RGL2 as an age-dependent factor regulates colon cancer progression
por: Cheng, Qingyu, et al.
Publicado: (2021)

Role of BraRGL1 in regulation of Brassica rapa bolting and flowering
por: Wang, Yudan, et al.
Publicado: (2023)

PsRGL1 negatively regulates chilling- and gibberellin-induced dormancy release by PsF-box1-mediated targeting for proteolytic degradation in tree peony
por: Gao, Linqiang, et al.
Publicado: (2023)

Inter- and intra-molecular interactions of Arabidopsis thaliana DELLA protein RGL1
por: Sheerin, David J., et al.
Publicado: (2011)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

Insights into the molecular mechanism of RGL2-mediated inhibition of seed germination in Arabidopsis thaliana
por: Stamm, Petra, et al.
Publicado: (2012)

The Ral Exchange Factor Rgl2 Promotes Cardiomyocyte Survival and Inhibits Cardiac Fibrosis
por: Scotland, Rebecca L., et al.
Publicado: (2013)

The Aspergillus fumigatus transcription factor RglT is important for gliotoxin biosynthesis and self-protection, and virulence
por: Ries, Laure N. A., et al.
Publicado: (2020)

DDX3 enhances oncogenic KRAS-induced tumor invasion in colorectal cancer via the β-catenin/ZEB1 axis
por: Wu, De-Wei, et al.
Publicado: (2016)

Downregulation of STK4 promotes colon cancer invasion/migration through blocking β‐catenin degradation
por: Lin, Cheng‐Han, et al.
Publicado: (2020)

BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
por: Li, Zi-Nan, et al.
Publicado: (2020)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
por: Chiu, I-Jen, et al.
Publicado: (2020)

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
por: Boutin, Adam T., et al.
Publicado: (2017)

The Rap1–Rgl–Ral signaling network regulates neuroblast cortical polarity and spindle orientation
por: Carmena, Ana, et al.
Publicado: (2011)

Insulated Switches: Dual-Function Protein RalGEF(RGL-1) Promotes Developmental Fidelity
por: Duong, Tam, et al.
Publicado: (2020)

KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
por: Xu, Jian-Ming, et al.
Publicado: (2014)

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
por: Hsu, Hung-Chih, et al.
Publicado: (2016)

Isolation and Role of PmRGL2 in GA-mediated Floral Bud Dormancy Release in Japanese Apricot (Prunus mume Siebold et Zucc.)
por: Lv, Lin, et al.
Publicado: (2018)

The NF-YC–RGL2 module integrates GA and ABA signalling to regulate seed germination in Arabidopsis
por: Liu, Xu, et al.
Publicado: (2016)

Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
por: Chang, Li-Chun, et al.
Publicado: (2014)

The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis
por: Cao, De-Dong, et al.
Publicado: (2017)

Effect of KRAS and NRAS mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases
por: Chuang, Shih-Chang, et al.
Publicado: (2020)

Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer
por: Lemieux, E, et al.
Publicado: (2015)

KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
por: PALIOGIANNIS, PANAGIOTIS, et al.
Publicado: (2014)

The predictive value of KRAS and NRAS mutations in metastatic colorectal cancer
por: Eshraghi, Abbas, et al.
Publicado: (2020)

Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
por: Chen, Yu, et al.
Publicado: (2015)

The involvement of Kras gene 3′-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis
por: Ying, Hou-Qun, et al.
Publicado: (2014)

Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer
por: Chen, Yen-Cheng, et al.
Publicado: (2022)

Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
por: Porru, Manuela, et al.
Publicado: (2018)

Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma
por: Ribeiro, Karen Bento, et al.
Publicado: (2013)

Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer
por: Ntavatzikos, Anastasios, et al.
Publicado: (2017)

Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
por: Ucar, Gokhan, et al.
Publicado: (2020)

KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
por: Radanova, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6h67j534su9k8s15lso6ee6187